Plus: House of Representatives aims to streamline health information technology system.
The days of fighting for SurgiMend payment for your ASC could be coming to a close.
Starting July 1, you'll be able to report four drugs and biologicals codes that Medicare will deem "separately payable" in ASCs, according to MLN Matters article MM6095.
The four new codes are as follows:
• C9242 -- Injection, fosaprepitant
• C9356 -- TendoGlide tendon prot, cm2
• C9357 -- Flowable wound matrix, 1 cc
• C9358 -- SurgiMend, per 0.5 cm2.
More good news: Also on the plus side, "no HCPCS...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: